Lovastatin inhibits lipopolysaccharide-induced NF-κB activation in human mesangial cells

Nephrology Dialysis Transplantation

Volumn 11, Issue 6, 1996, Pages 990-996

  Guijarro, C ^a   Kim, Y ^b   Schoonover, C M ^b   Massy, Z A ^a   O'Donnell, M P ^a   Kasiske, B L ^a   Keane, W F ^a   Kashtan, C E ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Farnesyl, lovastatin; LPS; Mesangial cells; Mevalonate; NF B

Indexed keywords

CHOLESTEROL; FARNESYL DIPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MEVALONIC ACID; MEVINOLIN; POLYCLONAL ANTIBODY; PROTEIN SUBUNIT; PYROPHOSPHORIC ACID DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY CELL CULTURE; KIDNEY INJURY; MESANGIUM CELL; PRIORITY JOURNAL;

BASE SEQUENCE; BLOOD; CELLS, CULTURED; ENZYME INHIBITORS; GLOMERULAR MESANGIUM; HUMANS; LIPOPOLYSACCHARIDES; LOVASTATIN; MEVALONIC ACID; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OLIGONUCLEOTIDE PROBES; TIME FACTORS;

EID: 0030003977     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.6.990     Document Type: Article

References (31)

1. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE. The activated mesangial cell: a glomerular 'myofibroblast'? J Am Soc Nephrol 1992; 2: S190-197
2. Sterzel RB, Schulze-Lohoff E, Weber M, Goodman SL. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix. J Am Soc Nephrol 1992; 2: S126-131
3. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141-179
4. Goidstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-430
5. Repko EM, Maltese WA. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J Biol Chem 1989; 264: 9945-9952
6. Guijarro C, Keane WF. Lipid-induced glomerular injury. Nephron 1994; 67: 1-6
7. Soma MR, Donetti E, Parolini C et al. HMG CoA reductase inhibitors - in vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb 1993; 13: 571-578
8. Walli AK, Gröne E, Gröne HJ, Seidel D. Reduction of lipid induced glomerulopathy by lovastatin without significant decrease of plasma cholesterol levels in guinea pigs. Circulation 1994; 94: I-233[Abstract]
9. Kauffman RF, Bean JS, Bensch WR. Reduction of intimal thickening by lovastatin in the absence of reductions in serum cholesterol. FASEB J 1994; 8: A319[Abstract]
10. O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF. Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 1993; 91: 83-87
11. Grandaliano G, Biswas P, Choudhury GG, Abboud HE. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells. Kidney Int 1993; 44: 503-508
12. Nakajima T, Kitajima I, Shin H et al. Involvement of NF-kappa B activation in thombin-induced human vascular smooth muscle cell proliferation. Biochem Biophvs Res Commun 1994; 204: 950-955
13. Law RE, Stimmel JB, Damore MA, Carter C, Clarke S, Wall R. Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5′-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions. Mol Cell Biol 1992; 12: 103-111
14. Müller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993; 187: 233-256
15. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540-546
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
17. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicilate and aspirin. Science 1994; 265: 956-959
18. Ulevitch RJ, Tobias PS. Recognition of endotoxin by cells leading to transmembrane signaling. Curr Opin Immunol 1994; 6: 125-130
19. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 1993; 90: 9887-9891
20. LeClair KP, Blanar MA, Sharp PA. The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc Natl Acad Sci USA 1992; 89: 8145-8149
21. Kunsch C, Ruben SM, Rosen CA. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Bio! 1992; 12: 4412-21
22. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270: 933-943
23. Satriano J, Schlöndorff D. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3′: 5′-cyclic monophosphate. Evidence for volvement of reactive oxygen species. J Clin Invest 1994; 94: 1629-1636
24. Khachigian LM, Collins T, Fries JWU. Nuclear factor-κB mediates induction of vascular cell adhesion molecule-1 in glomerular mesangial cells. Biochem Biophys Res Commun 1995; 206: 462-467
25. Terkeltaub R, Solan J, Barry M, Santoro D, Bokoch GM. Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells. J Leukocyte Biol 1994; 55: 749-755
26. Geng Y, Gulbins E, Altman A, Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci USA 1994; 91: 8602-8606
27. Reimann T, Büscher D, Hipskind RA, Krautwald S, Lohmann-Matthes M-L, Baccarini M. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1β and the TNF-α genes. J Immunol 1994; 153: 5740-5749
28. Finco TS, Baldwin AS. Kappa-B site-dependent induction of gene expression by diverse inducers of nuclear factor-kappa-B requires Raf-1. J Biol Chem 1993; 268: 17676-17679
29. Casey PJ, Solski PA, Der CJ, Buss JE. p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989; 86: 8323-8327
30. Kikuchi A, Williams LT. The post-translational modification of ras p21 is important for Raf-1 activation. J Biol Chem 1994; 269: 20054-20059
31. Yoshimura A, Inui K, Uda S, Sugenoya Y, Ideura T. HMG CoA reductase inhibitor suppresses initial macrophage infiltration and PDGF-induced mesangial cell proliferation in rats with mesangial proliferative nephritis in vivo. J Am Soc Nephrol 1994; 5: 789[Abstract]